CClinicalTrials.gg
RecruitingNCT07597980Updated Sep 3, 2026

Lifestyle Intervention to Improve Muscle Function in Older Adults

An interventional study of Structured nutrition plan and Typical or usual diet in Body Composition, Physical Function and Energy Balance, sponsored by Pennington Biomedical Research Center. Recruiting at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Pennington Biomedical Research Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance. The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise. The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise. Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week. Pre and post-intervention, body composition, physical function, and energy deficit will be measured.

Read the detailed description

In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity. A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge. This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake. The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group). The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.

02

Conditions studied

  • Body Composition
  • Physical Function
  • Energy Balance

Keywords

  • Fat mass
  • muscle mass
  • physical function
  • energy deficit
03

In context

Lead sponsor

Pennington Biomedical Research Center is the lead sponsor of 277 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age > 50 years.
  2. Body mass index (BMI) ≥ 30 kg/m2.
  3. Homeostatic model assessment of insulin resistance ≥ 3.
  4. Mini-Mental State Examination (MMSE) > 25.
  5. Geriatric Depression Scale-15 (GDS-15) \< 9.
  6. Sedentary (less than 90 minutes/week of moderate to vigorous activity).
  7. Ability to provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
  2. Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
  3. Fluctuation in body weight > 3 kg in the preceding two months
  4. Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Structured nutrition plan + exercise

    Intervention: Participants receive a structured nutrition plan, and exercise under supervision.

    Behavioral: Structured nutrition plan · Behavioral: Supervised Exercise

  • Active comparator
    Typical or usual diet + exercise

    Participants receive a typical or usual diet, and exercise under supervision

    Behavioral: Typical or usual diet · Behavioral: Supervised Exercise

Interventions

  • BehavioralStructured nutrition plan

    Participants will receive a structured nutrition plan.

  • BehavioralTypical or usual diet

    Participants will receive a diet representing the usual diet in this population.

  • BehavioralSupervised Exercise

    Participants will complete aerobic and resistance training under supervision three times per week.

06

What researchers measure

Primary outcomes

  1. Fat mass

    Fat mass measured by dual X-ray absorptiometry

    Time frame: Change from baseline to 12 weeks

Secondary outcomes

  1. Skeletal muscle mass

    Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method

    Time frame: Change in from baseline to 12 weeks

  2. Short physical performance battery

    A test of physical function

    Time frame: Change from baseline to 12 weeks

  3. Hand-grip strength

    Hand grip strength will be measured using a hand dynamometer

    Time frame: Change from baseline to 12 weeks

  4. Knee strength

    Knee strength will be measured quantified using Biodex dynamometry

    Time frame: Change from baseline to12 weeks

  5. Energy stores

    Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method

    Time frame: 12 weeks

  6. Hormonal regulation of energy balance

    Blood concentrations of glucagon-like peptide 1

    Time frame: Change from baseline to 12 weeks

  7. Hormonal regulation of energy balance

    Blood concentrations of gastric inhibitory peptide

    Time frame: Change from baseline to 12 weeks

  8. Hormonal regulation of energy balance

    Blood concentrations of cortisol

    Time frame: Change from baseline to 12 weeks

  9. Hormonal regulation of energy balance

    Blood concentrations of leptin

    Time frame: Change from baseline to 12 weeks

  10. Cardiorespiratory fitness

    VO2max

    Time frame: Change in VO2max from baseline to 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — At this time, we do not have plans to share IPD. We may consider it after the study results have been publicly disseminated

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07597980
Lead sponsor
Pennington Biomedical Research Center
Collaborators
National Institute on Aging (NIA)
Responsible party
Candida Rebello (Assistant Professor, Pennington Biomedical Research Center) — Principal investigator
First posted
May 20, 2026
Start date
Jul 20, 2026
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Sep 3, 2026

Study contacts

Candida J Rebello, PhD, RD
Contact
Candida.Rebello@pbrc.edu
12257633159
Reilly Roberts A Project Manager, MS
Contact
candidajoan@hotmail.com
225-763-2854
Candida J Rebello, PhD, RD
principal investigator · Pennington Biomedical Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion